发明名称 COMBINATION THERAPY FOR TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR TREATMENT OF CONDITIONS AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL
摘要 <P>PROBLEM TO BE SOLVED: To provide a new approach to lowering a blood glucose level in a subject and to increasing a blood GLP-1 level in a subject. <P>SOLUTION: The invention relates to combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level in a subject or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level. The invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011184458(A) 申请公布日期 2011.09.22
申请号 JP20110127707 申请日期 2011.06.07
申请人 ARENA PHARMACEUTICALS INC 发明人 CHU ZHI-LIANG;LEONARD JAMES N;AL-SHAMMA HUSSIEN A;JONES ROBERT M
分类号 A61K45/06;A61P9/10;A61P17/02;A61P25/02;A61P25/14;A61P25/16;A61P25/28;A61P43/00;C12N15/09 主分类号 A61K45/06
代理机构 代理人
主权项
地址